319
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol: in vitro evaluation and single versus multiple doses pharmacokinetic study in human volunteers

, ORCID Icon &
Pages 1777-1787 | Received 17 Jun 2019, Accepted 04 Aug 2019, Published online: 02 Sep 2019

References

  • Moore RA, Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol. 2008;8:11.
  • Mauleón D, Artigas R, García ML, et al. Preclinical and clinical development of dexketoprofen. Drugs. 1996;52:24–46.
  • Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons. 3rd ed. London: Pharmaceutical Press; 2003.
  • Barbanoj M-J, Antonijoan R-M, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet. 2001;40:245–262.
  • Laporte J-R, Ibáñez L, Vidal X, et al. Upper gastrointestinal bleeding associated with the use of NSAIDs – newer versus older agents. Drug Saf. 2004;27:411–420.
  • Gupta VK, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm. 2001;213:83–91.
  • Fukui E, Miyamura N, Uemura K, et al. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm. 2000;204:7–15.
  • Chandran S, Sanjay KS, Ali Asghar LF. Microspheres with pH modulated release: design and characterization of formulation variables for colonic delivery. J Microencapsul. 2009;26:420–431.
  • Evans D, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29:1035–1041.
  • Stefanic M, Vrecer F, Rizmal P, et al. Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions. Eur J Pharm Sci. 2014;62:8–15.
  • Vueba M, De Carvalho LB, Veiga F, et al. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur J Pharm Sci. 2004;58:51–59.
  • Petrovic A, Ibric S, Trajkovic S, et al. An investigation into effects of In Vitro Test condition on the release properties of theophylline from HPMC matrices using factorial design. Arch Pharm Res. 2009;32:1087–1096.
  • Sahoo J, Murthy P, Biswal S, et al. Comparative study of propranolol hydrochloride release from matrix tablets with Kollidon® SR or hydroxy propyl methyl cellulose. AAPS PharmSciTech. 2008;9:577–582.
  • Al-Tabakha MM, Arida AI, Fahelelbom KM, et al. Performances of new generation of delayed release capsules. J Young Pharm. 2015;7:37.
  • Pandey S, Mehta P, Patel H, et al. Novel time and site specific “tablets in capsule” system for nocturnal asthma treatment. J Pharm Investig. 2014;44:381–390.
  • Kramar A, Turk S, Vrečer F. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm. 2003;256:43–52.
  • Aleksovski A, Luštrik M, Šibanc R, et al. Design and evaluation of a specific, bi-phase extended release system based on differently coated mini-tablets. Eur J Pharm Sci. 2015;75:114–122.
  • Basalious EB, Abdullah A, Ibrahim M. Utility of mannitol and citric acid for enhancing the solubilizing and taste masking properties of β-cyclodextrin: development of fast-dissolving tablets containing extremely bitter drug. J Pharm Innov. 2014;9:309–320.
  • El-Setouhy DA, Basalious EB, Abdelmalak NS. Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: in vitro/in vivo evaluation. Eur J Pharm Biopharm. 2015;94:386–392.
  • British Pharmacopia. Appendix XII C. Consistency of formulated preparations, electronic version 18. UK: TSO; 2014.
  • Fouad SA, Shamma RN, Basalious EB, et al. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: in-vitro/in-vivo evaluation. Int J Pharm. 2016;505:212–222.
  • Costa P, Lobo JS. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm. 2001;27:811–817.
  • Pai R, Kohli K, Jain G, et al. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator. Arch Pharm Res. 2011;34:1135–1142.
  • El-Kamel A, Sokar M, Al Gamal S, et al. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001;220:13–21.
  • Shirsand SB, Suresh S, Jodhana LS, et al. Formulation design and optimization of fast disintegrating Lorazepam tablets by effervescent method. Indian J Pharm Sci. 2010;72:431–436.
  • Liu F, Merchant HA, Kulkarni RP, et al. Evolution of a physiological pH6. 8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Eur J Pharm Biopharm. 2011;78:151–157.
  • Sahoo J, Murthy P, Biswal S. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon® SR. AAPS PharmSciTech. 2009;10:27–33.
  • Sakr W, Alanazi F, Sakr A. Effect of Kollidon® SR on the release of albuterol sulphate from matrix tablets. Saudi Pharm J. 2011;19:19–27.
  • Khan MZI, Štedul HP, Kurjaković N. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit® L100 and Eudragit S100 combinations. Drug Dev Ind Pharm. 2000;26:549–554.
  • Hadi MA, Rao NR, Rao AS. Formulation and evaluation of pH-responsive mini-tablets for ileo-colonic targeted drug delivery. Trop J Pharm Res. 2014;13:1021–1029.
  • Hadi MA, Rao NR, Rao AS. Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis. Saudi Pharm J. 2016;24:64–73.
  • Baviskar D, Sharma R, Jain D. Formulation and in vitro/in vivo evaluation of sustained release diltiazem matrix tablets. Trop J Pharm Res. 2013;12:679–684.
  • Asghar LFA, Chandran S. Design and evaluation of matrix base with sigmoidal release profile for colon-specific delivery using a combination of Eudragit and non-ionic cellulose ether polymers. Drug Deliv Transl Res. 2011;1:132–146.
  • Narendra C, Srinath M, Rao BP. Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. Int J Pharm. 2005;304:102–114.
  • Vaghani S, Vasanti S, Chaturvedi K, et al. Formulation and evaluation of 5-FU loaded Eudragit microspheres: effect of various eudragit on micromeretic properties of microspheres. J Macromol Sci A. 2008;45:1015–1027.
  • Mehta R, Chawla A, Sharma P, et al. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system. J Adv Pharm Tech Res. 2013;4:31–41.
  • Stefan-van Staden R-I, Suzan Nhlapo N, Frederick van Staden J, et al. Enantioanalysis of S-ketoprofen using enantioselective, potentiometric membrane electrodes. Anal Lett. 2009;42:764–774.
  • Vemula SK. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: chronopharmaceutical delivery of ketorolac tromethamine. Int J Pharm. 2015;491:35–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.